about
Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtinNeurosteroid transport by the organic solute transporter OSTα-OSTβ.Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1.Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damageDrp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivoCyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.Glial cell response: A pathogenic factor in Parkinson's disease.Pathogenic role of glial cells in Parkinson's disease.Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activityAdenosine A1 receptors mediate local anti-nociceptive effects of acupunctureLocal anesthetics induce autophagy in young permanent tooth pulp cells.Glutathione dysregulation and the etiology and progression of human diseases.Cytosolic PINK1 escapes from mitochondria to promote dendritic outgrowth.Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP.Cultured astrocytes do not release adenosine during hypoxic conditions.Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease.Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes.Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteinsExosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition
P50
Q27312215-DA03999C-C025-44D7-BEEF-8CAE5F5EC441Q33637849-CA651307-CAA0-4355-BB3C-698EEC830A24Q33799876-31388AB8-9FFE-42FD-98D6-A86903B4531FQ34245037-8B155586-582D-4D60-ACB6-E9E9D0F9ABD2Q34470315-F8041844-22DA-45FF-8276-1F5D888EA7CCQ34983386-B32FBCA4-3785-47AF-BD4F-A2381581CD44Q35022594-E95D35B2-1247-4ED3-A754-3404BBAF61ABQ35050071-3F051B94-E9EE-47D5-89E6-969CD5557F17Q35651220-4C620AB9-C662-4494-9CDE-D63E4948C553Q35924978-4BB82F83-5A71-4C4B-B1E7-6D7259970A0AQ36307713-40C766B5-A35B-4FC6-BA58-3E1B1ACB9EB2Q37164319-6614132B-5A4A-44C3-A72C-793176B98F8DQ37372896-B72A31D8-D617-447F-986D-CCEC7DBCF255Q37633433-B00D7FFB-7A61-4044-B92D-4E8768A5F847Q39262071-AC7D53AA-1030-42B0-9961-2A76D709EC28Q39459866-CFFC9A1D-41AE-423D-9EAF-A579E2A14691Q41308603-D7E5122C-2B39-4EAB-8666-D58B882E0CD8Q43581257-5D556A65-3EEB-471D-86D9-A9F100E43671Q45297626-2CBFA06D-6A94-4105-AC15-C480AA553ECFQ45873646-50F8ACAC-C069-4C09-9BFD-7216ECE873F8Q47147993-4900D003-EC24-4F5B-8B23-A7BDBD56FA8BQ73075381-6BE5A8EB-53E8-4BD3-BA58-86A312153B92Q91342732-88436DF2-CA4C-42BF-9C41-C74E17EC7CBA
P50
description
researcher ORCID ID = 0000-0001-6606-4371
@en
wetenschapper
@nl
name
Kim Tieu
@ast
Kim Tieu
@en
Kim Tieu
@es
Kim Tieu
@nl
type
label
Kim Tieu
@ast
Kim Tieu
@en
Kim Tieu
@es
Kim Tieu
@nl
altLabel
Tieu K
@en
prefLabel
Kim Tieu
@ast
Kim Tieu
@en
Kim Tieu
@es
Kim Tieu
@nl
P108
P1053
F-5426-2012
P106
P2798
P31
P4012
P496
0000-0001-6606-4371